Clinical Trial Update: Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial of Proellex for symptomatic endometriosis in premenopausal women was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Endometriosis | Phase 2 | Status: TERMINATED | Results posted: 2014-08-25